Vincere Biosciences wins $2.7m NIH grant to advance acute kidney injury drug
Vincere Biosciences received a $2.7 million Small Business Innovation Research Phase II grant over two years from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to advance a USP30 inhibitor through IND-enabling studies for the treatme
<p>Vincere Biosciences received a $2.7 million Small Business Innovation Research Phase II grant over two years from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to advance a USP30 inhibitor through IND-enabling studies for the treatme</p>